Fig. 4From: Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patientsRelative rate of occurrence (%) of AKI events according to KDIGO stage 7 days following exposure to V, V/IC, and V/PT in adults (a) and children (b). *p < 0.05, ****p < 0.0001. IC imipenem-cilastin, KDIGO Kidney Disease Improving Global Outcomes, PT piperacillin-tazobactam, V vancomycinBack to article page